“The company knew that these drugs were important. They worked on them for 30 years. But they did not know how big they were going to be,” says the Financial Times’s Hannah Kuchler on this week’s Behind the Money, about megablockbusters #Wegovy and #Ozempic 🎧: link.chtbl.com/ftbehind-the-m…

News to kick off 2024: I've started as a pharmaceutical correspondent for the Financial Times, covering Hannah Kuchler for most of the year ahead. I'm very keen to chat to people in the pharma and biotech sector. If that's you, do get in touch!

As record numbers go to the polls in 2024, the FT launches a debate on what’s at stake with short films by four renowned artists via @ft Juliet Riddell roula khalaf ft.com/content/19e1ae…

We are at risk of yo-yoing between attention and neglect if pandemic preparedness becomes a political issue. Interesting interview with the chair of the 100 days mission by Ian Johnston ft.com/content/b2cc3b…

UK government eyes AstraZeneca manufacturing expansion deal, after drugmaker blamed a "discouraging tax rate" for choosing Ireland over the UK for a previous factory. With George Parker ft.com/content/d99166…

About a decade ago, Silicon Valley’s billionaires turned their attention to defeating death. Today, Philanthropist Nicole Shanahan is spending $100mn to find answers to fundamental questions about ovaries: on.ft.com/48WIROX

Congratulations to The #PressAwards Health Journalist category winner Sarah Neville / Financial Times

📣 #ABSWawards finalists announced 👉zurl.co/59TD 👀 Meet the 40 #finalists 👉zurl.co/9fT5 🏆 Join the Award Ceremony on July 3, at the Royal Institution, to meet the winners! ABSW Awards partners👏 ABPI @GilesDorrie The Royal Society AlphaGalileo

Excited to be shortlisted for the ABSW British science journalist of the year, alongside some great contenders Tom Whipple Joe Pinkstone and Jonathan O’Callaghan. absw.org.uk/pages/absw-awa…

Just finished this wonderful book by ⁦Yuan Yang⁩, who really brings alive today’s China through the stories of four women. Definitely worth reading.

Breaking news: Shares in Novo Nordisk have tumbled as much as 20% after the company's next-generation obesity drug Cagrisema missed its goal for an average of 25% weight loss on.ft.com/3P3JRbZ

Trump’s team wants US out of WHO ‘on day one’ As I said to Hannah Kuchler I think this would be a mistake It would leave America without intelligence for future emergencies and weaken our global leadership We should reform World Health Organization (WHO) Not abandon it ft.com/content/e6061e…

There are high hopes for #bonusseason in the City this year - but how does yours measure up? Early entries to the FT's Bonus Survey show the trend is for lower base pay and higher incentives... it's anonymous and fast if you're one of the lucky ones: feedback.ft.com/c/a/6ad3FHLID5…

Scoop: AstraZeneca ditches plans to invest in a vaccine manufacturing plant in Speke. With Anna Gross ft.com/content/289dba…

NEW: AstraZeneca has ditched plans to build new vaccine manufacturing plant in Merseyside, less than a year after it was first announced by Jeremy Hunt. The pharma giant blamed a low offer of state support from the new gov. W/⁦Hannah Kuchler⁩ on.ft.com/4gkFx38